Totally agree. It's going to take some time, but based on the evidence we've all seen about Amarex's work over the years, they are finished. We will own them. If Cytodyn sues for opportunity loss damages, it could be $1b + and that might be conservative.

Imagine our value with HIV approval already or Covid EUA...

NSF needs to brace itself. They WILL be brought back in to the pigpen.